Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events Score

References

1. 1.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Smith WS,
   2. Sung G,
   3. Saver J,
   4. et al

   . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12

   Abstract/FREE Full Text
3. 3.↵
   1. Smith WS,
   2. Sung G,
   3. Starkman S,
   4. et al

   . Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38

   Abstract/FREE Full Text
4. 4.↵
   1. Smith WS

   . Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177–82

   Abstract/FREE Full Text
5. 5.↵
   1. Flint AC,
   2. Duckwiler GR,
   3. Budzik RF,
   4. et al

   . Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274–80. Epub 2007 Mar 1

   Abstract/FREE Full Text
6. 6.↵
   1. Lutsep HL,
   2. Rymer MM,
   3. Nesbit GM

   . Vertebrobasilar revascularization rates and outcomes in the MERCI and multi-MERCI trials. J Stroke Cerebrovasc Dis 2008;17:55–57

   CrossRefPubMed
7. 7.↵
   1. Josephson SA,
   2. Saver JL,
   3. Smith WS

   . Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT II. Neurocrit Care 2009;10:43–49

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Williams DO,
   2. Borer J,
   3. Braunwald E,
   4. et al

   . Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI Thrombolysis in Myocardial Infarction trial. Circulation 1986;73:338–46

   Abstract/FREE Full Text
9. 9.↵
   1. Hallevi H,
   2. Barreto AD,
   3. Liebeskind DS,
   4. et al

   . Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2009;40:1780–85

   Abstract/FREE Full Text
10. 10.↵
    1. Flint AC,
    2. Smith WS

    . Predicting long-term outcomes for ischemic stroke based on admission variables. Stroke Rounds 2008;2:1–6
11. 11.↵
    1. del Zoppo GJ,
    2. Higashida RT,
    3. Furlan AJ,
    4. et al

    . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11

    Abstract/FREE Full Text
12. 12.↵
    1. Bose A,
    2. Henkes H,
    3. Alfke K,
    4. et al

    . The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409–13. Epub 2008 May 22

    Abstract/FREE Full Text
13. 13.↵
    1. Hill MD,
    2. Rowley HA,
    3. Adler F,
    4. et al

    . Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925–31

    Abstract/FREE Full Text
14. 14.↵
    THRIVE Score Calculator. Available at: http://www.thrivescore.org. Accessed March 9, 2010.